Pharma IQ’s Pharma Distribution Survey report

By Pharma Iq, PRNE
Sunday, June 19, 2011

LONDON, June 20, 2011 -

Pharma IQ has just published the results of an Industry-wide
Pharmaceutical Distribution Survey, conducted recently among 3,000
pharmaceutical distribution specialist with over 83 % of those
surveyed directly responsible for distribution at their respective

The results showed that that almost 75% of respondents are
satisfied with the current level of service they received from
external partners and solution providers they worked with at the
distribution stage, but despite this over 70% of respondents
expressed their interest in investing or working with different

With regard to the extent to which they trust their logistics
partners to deliver products quickly, safely and without damage,
the study revealed that 37.5 % of pharma distribution professionals
would rate their current level of trust at the eight-out-of-ten.
Half of respondents suggested that 75 % of shipments were being
distributed quickly, safely and with minimal loss of product
integrity and only half of all deliveries had reached the desired
quality standard.

The survey was created as a part of the pre-conference research
for href="">
Pharmaceutical Distribution Forum, taking place
13 - 15 September, 2011 in Amsterdam.

The results helped to shape the agenda and final speaker line-up
which features href="">
Paul Wolstencroft, Director, European Logistics from
Eli Lilly explaining the methodology employed at Eli Lilly
to facilitate the transition and Michael Grogan, Vice
President, Global Trade and Logistics from Actavis leading a
session on European Pharmaceutical Distribution:
Developing a Robust Strategy
- A Holistic

Other important topics expressed by survey respondents and will
be discussed at the event include:

  • Successfully launching a centralised distribution model in
    with insights and experiences from both Roland
    , Distribution Network Director EMEA,
    AstraZeneca and Hubert Koevoets, Director Transaction
    Management, Celgene
  • Risk mitigation in a global supply chain to improve product
    integrity and security (Menno Vliestra
    , Global Supply Chain,
    Finance and HR, Roche)
  • Ensuring fast, smooth and cost effective distribution into
    new markets
    with regional case studies from Bjorn Einar
    , Head of Nordic Supply Chain, Sanofi Aventis
    and Frank Binder, Director International
    Logistics & Supply Chain, Celgene
  • Securing the product and staying on top of serialisation
    with new updates from Grant Courtney, EFPIA representative
    and Global Serialisation Lead at GlaxoSmithKline

To access the full survey report or to find out
about Pharmaceutical Distribution 2011 please
Pharmaceutical Distribution’s website, email or call +44(0)20-7368-9421.

Media contact: Joanna, +44(0)20-7368-9421, href="">
 - Please contact for more information or images.

Press are invited to attend this
important industry forum, if you would like to a complimentary
press pass please email Joanna Checinska ( href="">


will not be displayed